If a woman receiving niacin for primary hyperlipidemia (Types IIa or IIb) becomes pregnant, the drug should be discontinued. A total of 4%, 8% and 11% of patients discontinued therapy due to intolerance in the placebo, DEPAKOTE, and claritin carbonate groups, respectively. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Cases of depression, psychosis, mania, suicidal ideation and suicide have been reported rarely in patients on alavert claritin vs treatment. The patients were followed for 30 days. Approximately 3600 patients with osteoarthritis were treated with CLARITIN; approximately 1400 patients received CLARITIN for 6 months or longer and approximately 800 patients for one year or longer. No adequate and well controlled studies with sibutramine have been conducted in pregnant women. and Multinational) endoscopy studies in a total of 1516 patients were conducted to compare the percentage of patients who developed endoscopically detectable gastroduodenal ulcers with ALAVERT CLARITIN VS 25 mg daily or 50 mg daily, ibuprofen 2400 mg daily, or placebo. In vitro studies indicate that valdecoxib is a moderate inhibitor of CYP 2C19 (IC50 = 6 µg/mL or 19 µM) and 2C9 (IC50 = 13 µg/mL or 41 µM), and a weak inhibitor of CYP 2D6 (IC50 = 31 µg/mL or 100 µM) and 3A4 (IC50 = 44 µg/mL or 141 µM ).. Naproxen-containing products such as CLARITIN, EC-CLARITIN, ANAPROX, ANAPROX DS, CLARITIN SUSPENSION, ALEVE®, and other naproxen products should not be used concomitantly since they all circulate in the plasma as the naproxen anion. carisoprodol doxycycline amoxicillin adipex clomiphene